Funded Tech Companies

ReVision Therapeutics

Wondering who provided funding to ReVision Therapeutics? Private investors and Avalon Ventures invested in this innovative biopharmaceutical company.

Company Overview

Company Name
ReVision Therapeutics
Company Status
Out of Business
Funding Rounds

Contact Information

Mailing Address
5626 Oberlin Drive 100
San Diego, CA 92121
USA
Email Address

Company Background Information

Overview
ReVision Therapeutics is focused on developing fenretinide for the treatment of age-related macular degeneration (AMD), the leading cause of blindness in the elderly.
Profile
ReVision Therapeutics LinkedIn Company Profile
Social Media
ReVision Therapeutics Company Twitter Account
Company News
ReVision Therapeutics News
Facebook
ReVision Therapeutics on Facebook
YouTube
ReVision Therapeutics on YouTube
Last Transaction
12/20/2011

Financing History

Date
Type
Amount
Venture Equity
$500,000
Venture Equity
$2,870,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
  Jay Lichter LinkedIn Profile  Jay Lichter Twitter Account  Jay Lichter News  Jay Lichter on Facebook
Chief Scientific Officer
Nathan Mata
  Nathan Mata LinkedIn Profile  Nathan Mata Twitter Account  Nathan Mata News  Nathan Mata on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Revision Optics | Revision3

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary